Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... mediate gene transcription and cellular proliferation in non-transformed and transformed prostate epithelial cells, as well as motility/invasiveness in transformed cells." ...
2009 NOV 28 ... than I came in," said McElvany, a school superintendent from Wewoka, Okla. treated for prostate cancer. "Few people can say that during cancer treatment. The folks here made me feel ...
2009 NOV 24 ... for dimebon (latrepirdine) for Alzheimer's and Huntington diseases and MDV3100 for prostate cancer. A live audio webcast of the presentation will be available on the ...
2009 NOV 26 ... we assessed the effects of piceatannol on the growth of androgen-insensitive DU145 prostate cancer cells at concentrations of 1-10 mu mol/L. Piceatannol reduced the viable numbers ...
2009 NOV 23 ... the United States, "Despite clear epidemiological and genetic evidence for X-linked prostate cancer risk, all prostate cancer genes identified are ...
2009 NOV 23 ... and molecular evidence suggest potential associations between exercise and prostate cancer risk reduction. We further characterized this relationship by examining exercise ...
2009 NOV 23 ... of biochemical recurrence and all cause mortality in patients with persistently elevated prostate specific antigen after radical prostatectomy in the Shared Equal Access Regional Cancer ...
2009 NOV 23 ... Systemic delivery of EGF-SubA results in a significant inhibition of human breast and prostate tumor xenografts in mouse models," wrote J.M. Backer and colleagues, SibTech, Inc. ...
2009 NOV 23 ... According to a study from the United States, "As the number of prostate cancer survivors increases, urologists must recognize their quality of life impairment. ...
2009 NOV 23 ... Investigators publish new data in the report 'The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.' "CC ...
2009 NOV 25 ... our PET-ultrasound phantom development, including PET and ultrasound images of a simple prostate phantom. We use agar and gelatin mixed with a radioactive solution. We also present our ...
2009 NOV 23 ... the United States, "The profound hypogonadism due to androgen deprivation therapy for prostate cancer results in complications such as sexual dysfunction, poor quality of life, ...
2009 NOV 23 ... research from the United States, "Although there is uncertainty about the effect of prostate-specific antigen (PSA) screening on the rate of...
2009 NOV 23 ... Investigators publish new data in the report 'Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen ...
2009 NOV 25 ... Insulation, "The effects of nanosecond pulsed electric fields (nsPEF) on the human prostate cancer cell line LNCaP was investigated for changes in protein and DNA concentrations as ...
2009 NOV 23 ... Investigators publish new data in the report 'Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices.' ...
2009 NOV 23 ... chordomas, chondrosarcomas and meningiomas as well as tumors of the salivary glands and prostate carcinomas. Brain tumors such as glioblastomas and low-grade astrocytomas will also be ...
2009 NOV 23 ... Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate ...
